Skip to main content
Premium Trial:

Request an Annual Quote

Inflammatix: João Fonseca

Inflammatix has appointed João Fonseca as chief technology officer to oversee its molecular assay development and engineering teams as the firm advances its rapid tests for acute infections, sepsis, and COVID-19 risk stratification.

Since 2006, Fonseca has served as founder, CEO, and chief scientific officer of Biosurfit, a Lisbon, Portugal-based company whose blood tests diagnose multiple conditions at the point of care. The company's tests are broadly available throughout Europe.

Prior to Biosurfit, Fonseca was a professor in physics and experimental physics at the Technical University of Lisbon and a researcher at the University of Lisbon. He also founded a non-profit organization that works with patients and researchers to advance novel cancer treatments and research.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.